Home / Nervous system / Hydroxyzine
ATC N05BB01 · Diphenylmethane Derivatives
Hydroxyzine shortage
As of 2 Nov 2026, Hydroxyzine has a reported shortage in 2 of the 15 countries we track (Canada, Norway), covering 4 products from 2 companies.
Countries2/15
Products4packs or presentations
Companies21 listed
Short since26 Mar 201412.6 years ago
Earliest return12 Nov 2026company estimate
Main reasonManufacturing problem
United StatesNo reported shortageCanada2 products shortGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorway2 products shortSwedenNo reported shortageJapanNo reported shortageAustraliaNo reported shortage
Timeline
CanadaNorway
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesListed: Teva TEVA · NYSE / TASE
Affected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | NOVO-HYDROXYZIN (100) | TEVA CANADA LIMITED | 26 Mar 2014 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | NOVO-HYDROXYZIN (100) | TEVA CANADA LIMITED | 26 Mar 2014 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| NO | Hydroxyzine Orifarm 10 mg tablett, filmdrasjert, 100 stk blisterpakning | Orifarm Generics A/S | 18 Sep 2026 | 12 Nov 2026 | Regulatory or licensing Regulatoriske problemer/utfordringer |
| NO | Hydroxyzine Orifarm 25 mg tablett, filmdrasjert, 100 stk blisterpakning | Orifarm Generics A/S | 18 Sep 2026 | 14 Dec 2026 | Regulatory or licensing Regulatoriske problemer/utfordringer |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.